Back to top

Image: Bigstock

Dolby's (DLB) Q2 Earnings & Revenues Beat Estimates, Up Y/Y

Read MoreHide Full Article

Dolby Laboratories, Inc (DLB - Free Report) reported second-quarter fiscal 2023 results, with the top and bottom lines surpassing the Zacks Consensus Estimate.

Non-GAAP earnings per share were $1.26 compared with 92 cents reported in the prior-year quarter. The bottom line surpassed the Zacks Consensus Estimate by 29.9%.

Total revenues were $375.9 million, up from $334.4 million in the year-ago quarter. The top line surpassed the Zacks Consensus Estimate by 8.3%. The uptick was caused by revenue growth across all business segments and increased adoption of Dolby Atmos and Dolby Vision.

The company announced a dividend of 27 cents per share, payable on May 23, to shareholders of record on May 16.

Dolby Laboratories Price, Consensus and EPS Surprise

Dolby Laboratories Price, Consensus and EPS Surprise

Dolby Laboratories price-consensus-eps-surprise-chart | Dolby Laboratories Quote

Segmental Performance

Revenues from Licensing were $351.6 million, up from $313.8 million reported in the prior-year quarter. Products and Services’ revenues were $24.2 million compared with $20.5 million reported in the year-ago quarter.

Broadcast Licensing contributed 37% to the total licensing revenues in the second quarter. Mobile Licensing accounted for 26%, Consumer Electronics 12%, PC Licensing 12% and Licensing from Other Markets contributed 13% to licensing revenues.

Other Details

Gross profit in the second quarter was $334.8 million compared with $298.8 million in the year-earlier quarter. Total operating expenses marginally declined to $225.8 million from $255.5 million reported in the previous-year quarter. Operating income was $109.2 million compared with $43.4 million in the year-ago quarter.

In the fiscal second quarter, the company repurchased 0.6 million of its common shares and ended the quarter with $262 million of stock repurchase authorization.

Cash Flow and Liquidity

In the fiscal second quarter, Dolby generated $104.5 million of net cash from operating activities compared with $63 million a year ago.

As of Mar 31, 2023, the company had $688.4 million in cash and cash equivalents, with $480.1 million in total liabilities.

Guidance

For the third quarter of fiscal 2023, the company expects GAAP earnings of 18-33 cents per share and non-GAAP earnings of 47-62 cents per share on revenues of $285-$315 million. On a GAAP basis, operating expenses are expected to be $227-$237 million, whereas, on a non-GAAP basis, operating expenses are anticipated to be $195-$205 million.

For fiscal 2023, the company expects revenues in the range of $1.27-$1.33 billion. GAAP operating margin is expected to be 19%, while the non-GAAP operating margin is expected to be nearly 30%. On a GAAP basis, operating expenses are expected to decline by 2%, whereas, on a non-GAAP basis, operating expenses are anticipated to increase by 2%.

Zacks Rank & Stocks to Consider

Dolby currently has a Zacks Rank #3 (Hold).

Some better-ranked stocks in the broader technology space are Dropbox (DBX - Free Report) , Badger Meter (BMI - Free Report) and Enfusion (ENFN - Free Report) , each sporting a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.

The Zacks Consensus Estimate for Dropbox’s 2023 earnings has increased 1.8% in the past 60 days to $1.71 per share. The long-term earnings growth rate is anticipated to be 11.5%.

Dropbox’s earnings beat the Zacks Consensus Estimate in the last four quarters, the average being 5.4%. Shares of DBX have increased 29% in the past year.

The Zacks Consensus Estimate for Badger Meter’s 2023 earnings has increased 4.7% in the past 60 days to $2.69 per share.

Badger Meter’s earnings beat the Zacks Consensus Estimate in all the last four quarters, the average being 5.3%. Shares of BMI have increased 122.4% in the past year.

The Zacks Consensus Estimate for Enfusion’s 2023 earnings has increased 5.6% in the past 60 days to 19 cents per share.

Enfusion’s earnings beat the Zacks Consensus Estimate in two of the last four quarters, the average surprise being 18.8%. Shares of the company have increased 3.2% in the past year.

Published in